Summit Therapeutics Presents Further Breakthrough Insights Surrounding the Novel Mechanism of Action for its Investigational Drug Ridinilazole During IDWeek 2021

NEXT STORY
Todos Medical Announces Positive Observational Trial Results for Oral Antiviral 3CL Protease (MPro) Inhibitor Tollovir®
PREV STORY
New Data Highlighting Itch Reduction with Topical Roflumilast in Multiple Dermatologic Conditions Presented at European Academy of Dermatology and Venereology Congress
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Immunovaccine Researchers to Present Data at Two Upcoming Conferences that Demonstrate the Broad Applicability of the Company’s DepoVax™-based Programs

Presentation at the 2017 SITC Meeting Will Highlight Preclinical Research on Predicting the Efficacy ...

author_avatar
NASDAQ Market News

FIT Biotech Oy: Conversion of FIT Biotech Oy’s Convertible Capital Notes into shares – last conversion of Bracknor financing programme

FIT Biotech Oy Company release February 26, 2018 at 5:30 PM EET Conversion of ...

author_avatar
NASDAQ Market News

Roivant Sciences Reports Financial Results for the Quarter Ended September 30, 2021 and Provides Business Update

author_avatar
NASDAQ Market News